Phase 3 Clinical Trial of CartiLife® in Korea

Clinical trial NCT05051332 · UNKNOWN

Trial details

NCT number: NCT05051332
Sponsor: Biosolution Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Articular Cartilage Defect Articular Cartilage Degeneration

Start date: 2020-03-19
Primary completion: 2023-09-30
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.